Pediatric cancer in low-income and middle-income countries
Ian Magrath(Uniformed Services University of the Health Sciences), Scott C. Howard(Hospital Sant Joan de Déu Barcelona), Sidnei Epelman(Hospital Santa Marcelina), Scott Macfarlane(Starship Children's Health), Mhamed Harif(Institut d’Hématologie et d’Oncologie Pédiatrique), Chi Kong Li(Chinese University of Hong Kong), Eva Steliarova‐Foucher(Centre international de recherche sur le cancer), Raul C. Ribeiro(St. Jude Children's Research Hospital), Rejin Kebudi(Koç University)
Unknown
January 1, 2013
Cited by 12
Related Papers
The Tumor Lysis Syndrome
|New England Journal of Medicine|2011|999
Preventing and Managing Toxicities of High-Dose Methotrexate
|The Oncologist|2016|920
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
|The Lancet|2009|453
Paediatric cancer in low-income and middle-income countries
|The Lancet Oncology|2013|432